- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06339736
Treatment Outcomes in Patients With Muscular Temporo-mandibular Joint Disorders
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Consecutive patients referred to the Unit of Dentistry and Oral Surgery for suspected TMD between January 2022 and December 2022 were enrolled. All the study participants signed an informed consent form to be included in the study.
Two study groups were identified:
- M-TMD group, including patients with a diagnosis of muscular TMDs;
- A control group of subjects with a negative history for TMDs. The inclusion criteria for patients in the M-TMD group were i) males or females >18 years, ii) systemically healthy patients, iii) clinical examination revealing a diagnosis of muscular TMD and/or positive history of muscular TMD, iv) patients willing to give informed consent, and v) compliance to the study follow-up. Patients with i) articular TMDs, ii) chronic diseases, iii) any psychiatric diagnosis under medication, iv) pregnant or lactating, and v) not willing to comply with the study protocol were excluded.
The subjects included in the control group were enrolled among the patients referred to the Unit of Oral Surgery of the Unit of Dentistry and Oral Surgery. The patients in the control group were i) males or females of age > 18 years, ii) systemically healthy patients, iii) clinical examination negative for pain in the masticatory muscles and negative for history of TMDs, and iv) patients willing to give informed consent and to be administered the study questionnaires.
After diagnosis confirmation of M-TMD according to the DC/TMD criteria, the patients were treated with the application of an oral splint on the upper dental arch associated with physio-kinesiotherapy.
The patients were administered OHIP-14, PHQ-9, and GAD-7 questionnaires to compare scores in the M-TMD patients versus healthy subjects
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Rossana Izzetti
- Phone Number: +39050993037
- Email: rossana.izzetti@unipi.it
Study Locations
-
-
-
Pisa, Italy, 56126
- Recruiting
- University of Pisa
-
Contact:
- Rossana Izzetti
- Phone Number: +39050993037
- Email: rossana.izzetti@unipi.it
-
Principal Investigator:
- Rossana Izzetti
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- males or females >18 years of age
- systemically healthy patients
- clinical examination revealing a diagnosis of muscular temporo-mandibular joint disorder (TMD) and/or positive history of muscular TMD
- patients willing to give informed consent, and v) compliance to the study follow-up.
Exclusion Criteria:
- articular TMDs
- chronic diseases
- any psychiatric diagnosis under medication
- pregnant or lactating females
- not willing to comply with the study protocol
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
M-TMD group
Patients with a diagnosis of muscular TMDs performed according to DC/TMD criteria
|
Ten treatment sessions were performed, which initially involved muscular stretching and relaxation exercises and then strengthening and endurance exercises to achieve stabilization.
An oral splint was applied to he upper dental arch.
|
CTRL group
A control group of subjects with a negative history for TMDs
|
Ten treatment sessions were performed, which initially involved muscular stretching and relaxation exercises and then strengthening and endurance exercises to achieve stabilization.
An oral splint was applied to he upper dental arch.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of the impact of muscular pain on oral health
Time Frame: 6 months
|
Assessment of Oral Health Impact Profile -14 (OHIP-14) questionnaire scores following treatment
|
6 months
|
Evaluation of the impact of muscular pain on anxiety
Time Frame: 6 months
|
Assessment of General Anxiety Disorder-7 (GAD-7) questionnaire scores following treatment
|
6 months
|
Evaluation of the impact of muscular pain on depression
Time Frame: 6 months
|
Assessment of Patient Health Questionnaire-9 (PHQ-9) questionnaire scores following treatment
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in muscular pain
Time Frame: 6 months
|
Changes in muscular pain following treatment assessed through pressure pain threshold
|
6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23815
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on TMD
-
University of L'AquilaCompleted
-
University of Maryland, BaltimoreNeuroscience Research AustraliaCompleted
-
Universidad Complutense de MadridUnknown
-
Yuzuncu Yıl UniversityCompleted
-
University of TorontoMount Sinai Hospital, CanadaUnknown
-
Shahid Beheshti UniversityUnknownTMDIran, Islamic Republic of
-
UConn HealthNational Institute of Dental and Craniofacial Research (NIDCR)Completed
Clinical Trials on Questionnaires administered to all study participants
-
Massachusetts General HospitalBill and Melinda Gates FoundationEnrolling by invitationGastrointestinal DiseaseUnited States
-
Sakakibara Heart InstituteCellBank of JapanUnknownChronic Heart Failure | Old Myocardial InfarctionJapan
-
Scancell LtdActive, not recruiting
-
Gilead SciencesWithdrawnTriple-negative Breast Cancer
-
Hope Biosciences Stem Cell Research FoundationHope BiosciencesRecruitingParkinson DiseaseUnited States
-
Shenzhen Center for Disease Control and PreventionCompletedPuberty, Precocious
-
Martina Hansen's HospitalHelse Sor-Ost; London School of Economics and Political ScienceUnknownRheumatoid Arthritis | Treatment ComplianceNorway
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; University of North Carolina, Chapel HillCompletedBreast CancerUnited States
-
University of AberdeenRecruitingLichen Planus, Oral | Lichen Planus of VulvaUnited Kingdom